MML Investors Services
GILD icon

MML Investors Services’s Gilead Sciences GILD Stock Holding History

MML Investors Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4M Buy
209,116
+36,566
+21% +$4.82M 0.05% 329
2026
Q1 		$24M Sell
172,550
-38,324
-18% -$5.37M 0.07% 287
2025
Q4 		$25.9M Buy
210,874
+14,980
+8% +$1.82M 0.06% 292
2025
Q3 		$21.7M Sell
195,894
-3,594
-2% -$409K 0.06% 314
2025
Q2 		$22.1M Sell
199,488
-8,978
-4% -$955K 0.06% 297
2025
Q1 		$23.4M Buy
208,466
+21,591
+12% +$2.23M 0.08% 255
2024
Q4 		$17.3M Sell
186,875
-3,814
-2% -$343K 0.06% 311
2024
Q3 		$16M Buy
190,689
+22,191
+13% +$1.69M 0.06% 312
2024
Q2 		$11.6M Sell
168,498
-9,678
-5% -$646K 0.05% 361
2024
Q1 		$13.1M Sell
178,176
-18,834
-10% -$1.45M 0.05% 336
2023
Q4 		$16M Buy
197,010
+14,854
+8% +$1.16M 0.07% 264
2023
Q3 		$13.7M Sell
182,156
-5,559
-3% -$428K 0.08% 258
2023
Q2 		$14.5M Sell
187,715
-1,115
-0.6% -$88.9K 0.08% 252
2023
Q1 		$15.7M Sell
188,830
-41,158
-18% -$3.41M 0.11% 206
2022
Q4 		$19.7M Buy
229,988
+16,340
+8% +$1.29M 0.13% 177
2022
Q3 		$13.2M Buy
213,648
+10,805
+5% +$681K 0.1% 228
2022
Q2 		$12.5M Buy
202,843
+24,213
+14% +$1.5M 0.1% 233
2022
Q1 		$10.6M Buy
178,630
+14,599
+9% +$933K 0.07% 267
2021
Q4 		$11.9M Buy
164,031
+2,951
+2% +$203K 0.09% 244
2021
Q3 		$11.3M Buy
161,080
+18,080
+13% +$1.27M 0.09% 249
2021
Q2 		$9.85M Buy
143,000
+2,880
+2% +$192K 0.08% 258
2021
Q1 		$9.06M Buy
140,120
+11,415
+9% +$736K 0.09% 244
2020
Q4 		$7.5M Sell
128,705
-4,500
-3% -$272K 0.08% 241
2020
Q3 		$8.42M Buy
133,205
+33,089
+33% +$2.29M 0.11% 200
2020
Q2 		$7.7M Sell
100,116
-17,969
-15% -$1.38M 0.1% 205
2020
Q1 		$8.83M Buy
118,085
+20,491
+21% +$1.42M 0.15% 166
2019
Q4 		$6.34M Buy
97,594
+4,989
+5% +$325K 0.09% 228
2019
Q3 		$5.87M Buy
92,605
+30,862
+50% +$2.02M 0.09% 219
2019
Q2 		$4.17M Buy
61,743
+1,935
+3% +$127K 0.06% 292
2019
Q1 		$3.89M Buy
59,808
+7,081
+13% +$471K 0.06% 287
2018
Q4 		$3.3M Sell
52,727
-4,880
-8% -$341K 0.06% 307
2018
Q3 		$4.45M Buy
57,607
+13,244
+30% +$1M 0.08% 252
2018
Q2 		$3.14M Buy
44,363
+1,454
+3% +$103K 0.07% 264
2018
Q1 		$3.23M Sell
42,909
-6,887
-14% -$547K 0.07% 252
2017
Q4 		$3.57M Buy
49,796
+3,464
+7% +$263K 0.07% 236
2017
Q3 		$3.75M Sell
46,332
-10,583
-19% -$809K 0.08% 216
2017
Q2 		$4.03M Buy
56,915
+7,955
+16% +$529K 0.08% 202
2017
Q1 		$3.33M Buy
+48,960
New +$3.44M 0.07% 103

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

MML Investors Services's GILD Position: Q2 2026 in Review

MML Investors Services increased its Gilead Sciences (GILD) stake by 21% in Q2 2026, buying an estimated $4.82M and bringing the position to 209,116 shares worth $26.4M. The position accounts for 0.05% of the portfolio, ranked #329.

MML Investors Services first reported a position in GILD in Q1 2017 and has held it in 38 quarters since. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MML Investors Services held 209,116 shares of Gilead Sciences worth $26.4M as of Q2 2026.
  • MML Investors Services bought 36,566 Gilead Sciences shares in Q2 2026, an estimated $4.82M.
  • Gilead Sciences made up 0.05% of MML Investors Services's portfolio in Q2 2026, its #329 holding.
  • MML Investors Services first reported a position in Gilead Sciences in Q1 2017 and has held it in 38 quarters since.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.